HSR25-167: Real-World Study Demonstrates Lack of Biomarker-driven Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer That Received Next-Generation Sequencing Testing
"HSR25-167: Real-World Study Demonstrates Lack of Biomarker-driven Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer That Received Next-Generation Sequencing Testing" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Tomoko Sugihara
- Melina E. Marmarelis (ORCID: https://orcid.org/0000-0003-2187-3583)
- Naleen Raj Bhandari (ORCID: https://orcid.org/0000-0002-4452-8021)
- Charu Aggarwal (ORCID: https://orcid.org/0000-0002-3181-9460)
- Tyler J. Marquart
- Sam Whipple
- Shen Zheng
- Adrienne M. Gilligan
Institutions
- Eli Lilly (United States) (US)
- Syneos Health (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7275
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00